Labonce Labonce-720FS Drug Stability Testing Chamber

Overview

The Labonce Labonce-720FS Drug Stability Testing Chamber is an engineered environmental simulation system designed specifically for long-term and accelerated stability studies of pharmaceutical products in accordance with ICH Q1A(R3), Q5C, and the Chinese Pharmacopoeia (ChP) 2020 edition. It operates on a precisely regulated dual-control principle—simultaneous independent control of temperature and relative humidity—using a high-efficiency refrigeration circuit coupled with a dedicated steam-based humidification system and capacitive humidity sensing. The chamber’s structural architecture integrates thermal inertia optimization, air distribution engineering (triple-directional bottom airflow), and multi-layer insulation to ensure spatial uniformity and temporal reproducibility—critical parameters for regulatory submissions under FDA, EMA, and NMPA review pathways.

Key Features

• Triple-directional bottom airflow design ensures uniform temperature and humidity distribution across the full 700 L working volume (±0.5 °C temperature uniformity; <±2 %RH humidity uniformity).
• High-density polyurethane foam insulation (≥120 mm thick) minimizes thermal bridging and moisture migration, sustaining stable internal conditions even under fluctuating ambient loads (+5 to +35 °C).
• Full mirror-finish 304 stainless steel interior chamber—non-porous, corrosion-resistant, and compliant with ISO 14644-1 Class 7 cleanroom-compatible cleaning protocols.
• 7-inch programmable color touchscreen controller with intuitive graphical interface, supporting up to 256-step programmable cycles and real-time deviation monitoring.
• Three-tier user permission system (Administrator, Supervisor, Operator) with individual login credentials, role-based access control, and encrypted password storage.
• FDA 21 CFR Part 11–compliant audit trail functionality: time-stamped, immutable records of all parameter changes, alarm events, door openings, and manual interventions—exportable via USB in read-only PDF or CSV format.
• Dual-door configuration: outer solid insulated door with magnetic gasket seal; inner tempered glass door enabling non-invasive sample observation without compromising chamber integrity.
• Redundant safety architecture including independent overtemperature cutoff, compressor overheat/overpressure protection, low-water cutoff, dry-run prevention, and phase-loss detection.

Sample Compatibility & Compliance

The Labonce-720FS accommodates diverse pharmaceutical dosage forms—including blister-packed tablets, vials, ampoules, syringes, sachets, and secondary packaging—on four standard adjustable stainless steel shelves (load capacity: 15 kg/shelf). Its interior geometry (975×575×1250 mm) permits vertical stacking of stability protocol-compliant storage trays while maintaining required air exchange rates per ICH guidelines. All materials contacting the chamber environment meet USP Class VI biocompatibility requirements. The system is preconfigured for compliance with GMP Annex 15 (Qualification of Utilities and Facilities), WHO TRS 986 Annex 9, and EU GMP Annex 11 (Computerized Systems), supporting IQ/OQ/PQ documentation packages upon request.

Software & Data Management

The integrated network-capable monitoring software (Labonce StabilitySuite™) provides centralized remote supervision of multiple chambers via secure HTTPS/TLS 1.2 communication. It supports automated data logging at user-defined intervals (1 s to 24 h), configurable alarm thresholds, email/SMS notification escalation, and electronic signature workflows. All stored data are timestamped, digitally signed, and protected against unauthorized modification—fully satisfying ALCOA+ principles (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available). Raw data archives comply with 21 CFR Part 11 Subpart B requirements for record retention (minimum 2 years post-study completion) and support eTMF integration.

Applications

• ICH Q1A(R3)-mandated long-term (25 °C/60 %RH, 30 °C/65 %RH) and accelerated (40 °C/75 %RH) stability testing.
• Photostability assessment when paired with optional UV/visible light modules (IEC 60601-2-57 compliant).
• Excipient compatibility screening under controlled hygroscopic stress conditions.
• Real-time shelf-life determination for generic drug products seeking ANDA or Dossier submission.
• Process validation support for lyophilization cycle development and container-closure integrity verification.
• Stability-indicating method development and forced degradation studies per ICH Q5C.

FAQ

Does the Labonce-720FS support IQ/OQ/PQ qualification documentation?
Yes—factory-supplied qualification templates aligned with ASTM E2500-13 and ISPE GAMP 5 are provided, including test protocols, evidence logs, and summary reports.
Is remote monitoring available without additional hardware?
Yes—the built-in Ethernet port and embedded web server enable browser-based access from any authorized workstation without requiring third-party gateways.
Can humidity be maintained below 20% RH?
No—the operational humidity range is specified as 10–80% RH; sub-20% RH requires desiccant-based auxiliary systems not integrated into this model.
What is the validation status of the capacitive humidity sensor?
The Vaisala HUMICAP® sensor is factory-calibrated traceable to NIST standards, with documented calibration certificate and drift specification (<±0.5%RH/year) supplied with each unit.
Are shelf load limits defined per ICH Q5C?
Yes—maximum loading is validated to maintain ≤±0.5 °C spatial uniformity at 40 °C/75%RH with 80% volume occupancy, meeting ICH-recommended airflow obstruction thresholds.